Physician profile
Deborah Hamby
NPI 1972503183
$3,157.14
in general payments reported to CMS, 2019-2025
32 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $529 · 2020: $184 · 2021: $385 · 2022: $881 · 2023: $619 · 2024: $270 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $496.05 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $290.12 | 2021-2025 | |
| Myovant Sciences INC. | $228.75 | 2021-2022 | |
| Therapeuticsmd, INC. | $203.59 | 2019-2022 | |
| Evofem Biosciences, INC. | $200.06 | 2021-2022 | |
| Organon LLC | $195.71 | 2022-2025 | Nexplanon |
| Lupin INC. | $185.47 | 2019-2020 | |
| Daiichi Sankyo INC. | $171.88 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $168.49 | 2021-2024 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $141.99 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Pfizer INC. | $96.78 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $96.73 | 2023-2025 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $64.07 | 2019 | |
| Hologic Sales and Service, LLC | $60.02 | 2022-2023 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $55.16 | 2020-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Channel Medsystems, INC. | $53.47 | 2025 | |
| Exeltis, USA INC. | $48.32 | 2024 | Slynd |
| Amgen INC. | $46.49 | 2021-2025 | Evenity |
| Shield Therapeutics INC | $45.99 | 2022-2023 | Accrufer |
| Avion Pharmaceuticals | $44.87 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $37.01 | 2019-2022 | |
| Vertical Pharmaceuticals, LLC | $34.79 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.18 | 2022-2023 | |
| Boston Scientific Corporation | $29.37 | 2024 | |
| Baxter Healthcare | $21.52 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Smith+Nephew, INC. | $20.76 | 2022 | |
| Meditrina | $20.48 | 2023-2024 | |
| Medtronic, INC. | $19.04 | 2024 | Truclear |
| Axonics, INC. | $15.04 | 2022 | |
| Octapharma USA, INC. | $14.91 | 2025 | Fibryga |
| Exact Sciences Corporation | $14.68 | 2025 | Cologuard Collection Kit |
| Millicent US INC | $2.35 | 2024 | Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Hamby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.